Literature DB >> 2073132

Detoxification of soman in the perfused rat liver: quantitative uptake and stereoisomer metabolism.

A Wahlländer1, L Szinicz.   

Abstract

The detoxification of soman (1,2,2-dimethyl-propyl methylphosphonofluoridate) was measured in rat livers, using hemoglobin-free, non-recirculating perfusion in situ. Since the detoxification processes may differ in perivenous and periportal zones of liver parenchyma, soman uptake, stereoselective metabolism and inhibition of esterases were compared in antegrade and retrograde perfusion experiments. At low concentrations of soman (up to about 10 mumol l-1 for 5 min) soman was taken up by the liver nearly quantitatively. About 5% recovery rate in the perfusate corresponded well to the intrahepatic shunt flow. Infusions of higher amounts yielded increasing recovery rates. The racemic infusion medium contained the four isomers of soman, C(-)P(-) to C(+)P(+), in nearly identical amounts, whereas in the effluent perfusate only P(-) isomers were found. Even small amounts of soman (5-120 nmol g-1 liver wet weight) caused significant inhibition of hepatic aliesterase activity. Doses higher than 200 nmol g-1 suppressed esterase activity by more than 90%. No essential differences in soman uptake, stereoselective metabolism or inhibition of esterases were found between antegrade and retrograde perfusion experiments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073132     DOI: 10.1007/BF01971839

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

1.  The handling of indocyanine green by the liver.

Authors:  G Paumgartner
Journal:  Schweiz Med Wochenschr       Date:  1975

2.  Problems in the therapy of Soman poisoning.

Authors:  O L Wolthuis; F Berends; E Meeter
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr

3.  Interaction of the four stereoisomers of soman (pinacolyl methylphosphonofluoridate) with acetylcholinesterase and neuropathy target esterase of hen brain.

Authors:  M K Johnson; D J Read; H P Benschop
Journal:  Biochem Pharmacol       Date:  1985-06-01       Impact factor: 5.858

4.  The mechanism of soman detoxification in perfused rat liver.

Authors:  S H Sterri; G Valdal; S Lyngaas; E Odden; D Malthe-Sørenssen; F Fonnum
Journal:  Biochem Pharmacol       Date:  1983-06-15       Impact factor: 5.858

5.  Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman.

Authors:  H P Benschop; C A Konings; J Van Genderen; L P De Jong
Journal:  Toxicol Appl Pharmacol       Date:  1984-01       Impact factor: 4.219

6.  Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis.

Authors:  J Reichen; A Hirlinger; H R Ha; S Sägesser
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

7.  Toxicity of soman after repetitive injection of sublethal doses in rat.

Authors:  S H Sterri; S Lyngaas; F Fonnum
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-01

8.  Stabilization and gas chromatographic analysis of the four stereoisomers of 1,2,2-trimethylpropyl methylphosphonofluoridate (soman) in rat blood.

Authors:  H P Benschop; E C Bijleveld; M F Otto; C E Degenhardt; H P Van Helden; L P De Jong
Journal:  Anal Biochem       Date:  1985-12       Impact factor: 3.365

9.  Evidence for an intramuscular depot of the cholinesterase inhibitor soman in the rat.

Authors:  H P Van Helden; O L Wolthuis
Journal:  Eur J Pharmacol       Date:  1983-05-06       Impact factor: 4.432

10.  Further evidence for the effect of pinacolyl dimethylphosphinate on soman storage in muscle tissue.

Authors:  C J Van Dongen; H P Van Helden; O L Wolthuis
Journal:  Eur J Pharmacol       Date:  1986-08-07       Impact factor: 4.432

View more
  1 in total

Review 1.  Pharmacokinetics and molecular detoxication.

Authors:  J R Cashman; B Y Perotti; C E Berkman; J Lin
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.